Sign In
Buy APRE
$0.762
-0.0022 (-0.288%)
At Close: Jun 03, 2026
Most people get personal loans for debt consolidation—here's the average amount
07:58pm, Thursday, 18'th Jun 2020
CNBC Select shares how high the average debt consolidation and credit card refinancing loans were in early 2020 and explains how a personal loan can save you money.
Successfully Refinancing Your Mortgage Isn’t Just About Getting A Great Interest Rate. Here’s What Else You Need To Look For
12:00am, Wednesday, 17'th Jun 2020
Your interest rate isn't the only important factor when refinancing.
NewsCrypto to Change The Cryptocurrency Staking Game? | BTCMANAGER
08:56am, Tuesday, 16'th Jun 2020
Staking is a quickly gaining popularity in the world of cryptocurrency, as the process of earning a profit while helping to secure the underlying network is an attractive proposition. After all, by st
Aprea Therapeutics (NASDAQ:APRE) Director Scott M. Rocklage Sells 245,000 Shares
05:56am, Tuesday, 16'th Jun 2020
Aprea Therapeutics (NASDAQ:APRE) Director Scott M. Rocklage sold 245,000 shares of the business’s stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $28.75,
Midfielder Mukunzi believes he still has room for improvement
06:43pm, Monday, 15'th Jun 2020Oregon State awards wrestling coach Chris Pendleton with a five-year, $825,000 contract
03:49pm, Monday, 15'th Jun 2020
Pendleton was hired in April to replace Jim Zalesky
Amazon Offers A Line Of Credit To Select Sellers
12:00am, Monday, 15'th Jun 2020
The line of credit, issued through Goldman Sach's Marcus bank brand, will include an APR starting at 6.99% on a credit line of up to $1 million.
Innocent Nshuti: Tracing the meteoric rise of the APR star
10:05pm, Friday, 12'th Jun 2020Hedge Funds Warming Up To Aprea Therapeutics, Inc. (APRE)
08:15pm, Friday, 12'th Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Aprea Therapeutics, Inc. (NASDAQ:APRE) and determine whether it is a good investment right now. We at Insider Monkey l
Aprea Therapeutics, Inc. (APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, today announced
Aprea Therapeutics (APRE) in Focus: Stock Moves 5.8% Higher
02:44am, Friday, 12'th Jun 2020
Aprea Therapeutics (APRE) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Just The Classics: One Man’s Journey In Jazz And Aviation In St. Louis
12:00am, Friday, 12'th Jun 2020
Torrini’s championing of the 62-year-old Phantom jet-still flown by several air forces-sprang from a conviction that the old and powerful could remain new and vibrant with a little thoughtful evolut
How To Transfer Your Credit Card Balance
12:09am, Thursday, 11'th Jun 2020
Transferring a credit card balance is easy.
Is Aprea Therapeutics Stock a Buy?
01:39pm, Wednesday, 10'th Jun 2020
Here's why this biotech company with a promising treatment for a rare blood disorder is a solid buy.
